Recruiting Trials   

volunteer
vaccine scrabble
H1N1
 
clinical trial image
 

Tuberculosis

TB043 – A BCG challenge study in healthy adults to help develop TB vaccines. If you are aged 18-50, in good health, and have never received the BCG vaccine, you may be eligible to participate. The study involves 9 visits over a period of around 6 months. Participants will be reimbursed for their time and travel from £685 to £725. For more detailed information about this trial, please click here

Malaria 

VAC069 Malaria Challenge Study - We are looking for healthy volunteers aged 18-50 to take part in our malaria challenge study. The study is over a 2 year period and volunteers will be compensated up to approximately £6855 for their time, inconvenience and travel. Click here for more information.

VAC071 Malaria Challenge Study - Are you aged 18-45 and never had malaria? You may be eligible to participate in our challenge trial assessing a new malaria vaccine. The trial will involve a number of visits over a 1 year period, with an intense visit schedule for the 4 weeks following malaria infection. Participants will be reimbursed up to £3320 for their time, travel and incovenience.

VAC072 Malaria Challenge Study Trial – a study to assess the effectiveness of novel malaria vaccine candidates by infecting vaccinated volunteers with malaria parasites. This study is over a 3-19 month period and volunteers will be compensated for their time, inconvenience and travel (up to £2730). If you are aged 18-45, are in good health and never had malaria, you may be eligible to participate. Click here for more information.

Mycobacterium avium subspecies paratuberculosis (MAP)

HAV001 A phase I clinical trial to determine the safety and immunogenicity of the candidate Mycobacterium avium subspecies paratuberculosis (MAP) vaccine ChAdOx2 HAV and MVA HAV in healthy adult volunteers. The study involves 7-12 visits to our out-patient department over a 3-5 month period, with reimbursement of £300-£530 for time and travel (depending on trial group). If you are aged 18-50 and are in good health, you may be eligible to participate.  For more detailed information about this trial, please click here.

HPV (Human papillomavirus)

HR HPV Study Defining the high risk human papillomavirus (HR HPV) specific T-cell repertoire in human subjects using a proteome wide approach.  For more detailed information about this trial, please click here.

 

Please note that for certain studies, we work with other sites around the UK and your data submitted through pre-screening questionnaire may be shared with them if necessary. You will be informed of this in advance by email and will have the option to opt out.  

 

Would you like to keep up to date with trials?

If you would like to register with us to receive our monthly email newsletter detailing our latest trials looking for volunteers, please click here.